Top Markets
#1 QuantixAI QuantixAI +102.83%
#2 MetaDAO MetaDAO +25.95%
#3 Pons Pons +24.24%
#4 龙虾 (Lobster) 龙虾 (Lobster) +24.22%
#5 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +23.90%
#6 Rain Rain +21.63%
#7 Bedrock Bedrock +21.41%
#8 Ontology Gas Ontology Gas +20.44%
#9 SPX6900 SPX6900 +18.25%
#10 Prom Prom +18.01%
Coin of the day
QuantixAI QuantixAI
設定
言語
日本
通貨
USD
テーマ
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
株式のランク #20256
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
株価
$1.90
時価総額
$135.79M
変化（1日）
-0.50%
変化（1年）
20.89%
国
TW
取引 Sinew Pharma Inc. (6634)

カテゴリー

Healthcare
Sinew Pharma Inc.（6634）の配当履歴
Sinew Pharma Inc.（証券コード：6634）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのSinew Pharma Inc.（6634）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH